Interferon lambda 1 is associated with dengue severity in Thailand.
Dengue
Disease severity
Genetic association
IFNL1
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
25
10
2019
revised:
07
01
2020
accepted:
14
01
2020
pubmed:
26
1
2020
medline:
1
7
2020
entrez:
26
1
2020
Statut:
ppublish
Résumé
Patients with dengue exhibit a range of symptoms from an acute febrile illness (dengue fever, DF), to dengue hemorrhagic fever (DHF), and to the most severe outcome, dengue shock syndrome (DSS). This study was performed to determine the host genetic factors responsible for dengue severity. Two single nucleotide polymorphisms (SNPs) of the interferon lambda 1 (IFNL1) gene (rs30461 and rs7247086) were analyzed for their association with dengue severity in a Thai population. This was a case-control association study involving 877 patients under the age of 15 years (DF, n = 386; DHF, n = 416; DSS, n = 75). Genotyping was performed by TaqMan real-time PCR assay. It was found that the rs7247086 variant of IFNL1 was associated with DHF, but not DSS. Genotypes CT and TT and the T allele were protective against DHF (p = 0.03, odds ratio 0.62 for CT, odds ratio 0.13 for TT; and p = 0.01, odds ratio 0.54 for the T allele). The other SNP tested was not associated with DHF or DSS. The rs7247086 variant of IFNL1 (the T allele) was found to be protective against DHF, suggesting that IFNL1 may play a role in the pathogenesis of DHF.
Identifiants
pubmed: 31981768
pii: S1201-9712(20)30028-X
doi: 10.1016/j.ijid.2020.01.026
pii:
doi:
Substances chimiques
interferon-lambda, human
0
Interleukins
0
Interferons
9008-11-1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
121-125Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.